Free Trial

Beauty Health Q2 2023 Earnings Report

Beauty Health logo
$1.61 +0.02 (+1.26%)
(As of 05:21 PM ET)

Beauty Health EPS Results

Actual EPS
$0.03
Consensus EPS
$0.05
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.09

Beauty Health Revenue Results

Actual Revenue
$117.50 million
Expected Revenue
$114.89 million
Beat/Miss
Beat by +$2.61 million
YoY Revenue Growth
+13.50%

Beauty Health Announcement Details

Quarter
Q2 2023
Time
Before Market Opens

Conference Call Resources

Most People Are Dead Wrong. (Ad)

Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Beauty Health Earnings Headlines

Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
Winter weddings: Expert tips for radiant skin
See More Beauty Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Beauty Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beauty Health and other key companies, straight to your email.

About Beauty Health

Beauty Health (NASDAQ:SKIN) designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

View Beauty Health Profile

More Earnings Resources from MarketBeat